ANGO (AngioDynamics Corp) Market Value to Book Value Ratio

AngioDynamics Corp (ANGO) - corporate logo

The AngioDynamics, Inc. (ANGO) price chart reflects the performance of a company that automates the production of surgical instruments using robotics to enhance precision and cost-efficiency. The business is implementing nanosecond ablation, which enables the safe removal of neoplasms without causing burns. The current indicator stands at 3.16, while profitability is sustained through a focus on high-cost proprietary developments for vascular surgery and oncology.

ANGO - AngioDynamics Inc. Market-to-Book Ratio over the range 07/04/2022 - 10/28/2026
Manufactured products of AngioDynamics Inc

To protect capital amid volatility, it is essential for investors to compare the current market value of AngioDynamics, Inc. (ANGO) with its net asset value, which allows them to determine the degree of overvaluation or the presence of a deep discount via a chart of the market cap to book value multiple. This multiplier reflects the market premium on capital, which in the case of AngioDynamics, Inc. (ANGO) is justified by the implementation of high-precision robotic lines that reduce production costs.

Direct competitors

Market Value to Book Value Ratio ISRG|DHR (danaher.com) - Market-to-Book Ratio|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio CERS (Cerus Corporation)|TKNO: Market Capitalization to Book Value|Market Value to Book Value Ratio Monogram Orthopedics|STSS (Sharps Technology) - Capitalization to Book Value Ratio|INFU: Market Value to Book Value Ratio|Market Capitalization to Book Value Utah Med (UTMD)|Market Cap to Net Assets Ratio KORU Medical Systems|Market Cap to Book Value Multiple NYXH (nyxoah.com)|Market Value to Book Value Ratio Microbot Medical|PDEX - Market Value to Book Value|Zentek Limited - Market Cap to Net Assets Ratio|ELUT: Market Capitalization to Book Value Ratio|MLSS (Milestone Scientific) - Market Value to Book Value Ratio|nexgel.com (NXGL) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO - Market Capitalization to Book Value